New DEA Classification is Getting Closer!!
The United States stands at a historic, potentially decisive crossroads for cannabis policy. Public transcripts and filings from the DEA rescheduling hearing recently revealed the agency’s official brief, which strongly advocates for moving cannabis to Schedule III. Seeing this pro-medical stance formally signed by the DEA Administrator marks a stunning reversal after decades of strict […]
